SCHEMBL2035178

SCHEMBL2035178

CC(Sc1cccc(C(F)(F)F)c1)c1ccnc(N)n1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HRH4 Q9H3N8 3/20 0.43
GRM5 P41594 1/20 0.40
POLB P06746 1/20 0.39
KDM4E B2RXH2 2/20 0.39
ADORA2A P29274 1/20 0.38
ADORA1 P30542 1/20 0.38
ROCK1 Q13464 1/20 0.38
NOS3 P29474 1/20 0.38
NOS2 P35228 1/20 0.38
CDK2 P24941 2/20 0.38
CDC7 O00311 1/20 0.38
CCNT1 O60563 1/20 0.38
CCNA2 P20248 1/20 0.38
CDK9 P50750 1/20 0.38
HPGD P15428 1/20 0.38
XBP1 P17861 1/20 0.38
GPR52 Q9Y2T5 1/20 0.37
HTR2A P28223 1/20 0.37
HTR2C P28335 1/20 0.37
HTR2B P41595 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2035177 1.00 HRH4 (0.43) HRH4GRM5POLBKDM4EADORA2A
SCHEMBL2034075 0.83 GRM4 (0.43) HRH4POLBROCK1CDK2CDC7
SCHEMBL2034077 0.83 GRM4 (0.43) HRH4POLBROCK1CDK2CDC7
SCHEMBL2032647 0.75 POLB (0.65) HRH4POLBKDM4EADORA2AALDH1A1
SCHEMBL2034010 0.75 PKM (0.43) HRH4POLBKDM4EHPGDMEN1
SCHEMBL2033840 0.74 POLB (0.41) HRH4POLBADORA2AADORA1CDK2
SCHEMBL11449928 0.72 HTR2A (0.53) KDM4EHPGDXBP1HTR2AHTR2C
SCHEMBL10297511 0.71 HTR2A (0.47) KDM4EHPGDXBP1HTR2AHTR2C
SCHEMBL28975159 0.70 HTR2A (0.46) KDM4EHPGDXBP1HTR2AHTR2C
SCHEMBL28121523 0.69 PDE2A (0.48) HRH4POLBNOS3NOS2CDK2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2516397-B1 Amino-heteroaryl derivatives as HCN blockers MERCK SHARP & DOHME (NL) 2016-07-13 EP disclosed
US-8952001-B2 Amino-heteroaryl derivatives as HCN blockers MERCK SHARP & DOHME CORP. (US) 2015-02-10 US disclosed
CN-102884048-B Amino-heteroaryl derivatives as HCN blockers MSD OSS BV 2014-07-23 CN disclosed
CN-102884048-A Amino-heteroaryl derivatives as HCN blockers MSD OSS BV 2013-01-16 CN disclosed
EP-2516397-A1 AMINO-HETEROARYL DERIVATIVES AS HCN BLOCKERS MSD Oss B.V. (NL) 2012-10-31 EP disclosed
US-20120264728-A1 AMINO-HETEROARYL DERIVATIVES AS HCN BLOCKERS ORGANON BIOSCIENCES NEDERLAND B.V. (NL) 2012-10-18 US disclosed
WO-2011076723-A1 AMINO-HETEROARYL DERIVATIVES AS HCN BLOCKERS N.V. ORGANON (NL) 2011-06-30 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120264728-A1 AMINO-HETEROARYL DERIVATIVES AS HCN BLOCKERS HCN1, HCN3, HCN2 HRH4 54/4885GRM5 436/4885POLB 3931/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.